ACRBP (NM_032489) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC205415L2V
- LentiORF®
Lenti ORF particles, ACRBP (mGFP-tagged) - Human acrosin binding protein (ACRBP), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 9,975.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | ACRBP (NM_032489) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | CT23; OY-TES-1; SP32 |
Vector | pLenti-C-mGFP |
ACCN | NM_032489 |
ORF Size | 1629 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC205415).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_032489.2 |
RefSeq Size | 1886 bp |
RefSeq ORF | 1632 bp |
Locus ID | 84519 |
Protein Families | Secreted Protein |
MW | 61.4 kDa |
Gene Summary | The protein encoded by this gene is similar to proacrosin binding protein sp32 precursor found in mouse, guinea pig, and pig. This protein is located in the sperm acrosome and is thought to function as a binding protein to proacrosin for packaging and condensation of the acrosin zymogen in the acrosomal matrix. This protein is a member of the cancer/testis family of antigens and it is found to be immunogenic. In normal tissues, this mRNA is expressed only in testis, whereas it is detected in a range of different tumor types such as bladder, breast, lung, liver, and colon. [provided by RefSeq, Jul 2008] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...